216 related articles for article (PubMed ID: 37378536)
1. Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high-risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves.
Zeitler K; Piccicacco N; O'Neal M; Montero J; Myers A; Strebig D; Nestler S; Anger LB; Kim K
Transpl Infect Dis; 2023 Aug; 25(4):e14095. PubMed ID: 37378536
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch.
Yetmar ZA; Beam E; O'Horo JC; Seville MT; Brumble L; Ganesh R; Razonable RR
Transpl Infect Dis; 2022 Aug; 24(4):e13901. PubMed ID: 35848574
[TBL] [Abstract][Full Text] [Related]
3. Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients.
Yetmar ZA; Bhaimia E; Razonable RR
Curr Opin Organ Transplant; 2022 Aug; 27(4):269-276. PubMed ID: 36354253
[TBL] [Abstract][Full Text] [Related]
4. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
[TBL] [Abstract][Full Text] [Related]
5. Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
Karaba AH; Zhou W; Li S; Aytenfisu TY; Johnston TS; Akinde O; Eby Y; Abedon AT; Alejo JL; Qin CX; Thompson EA; Garonzik-Wang JM; Blankson JN; Cox AL; Bailey JR; Klein SL; Pekosz A; Segev DL; Tobian AAR; Werbel WA
Clin Infect Dis; 2023 Feb; 76(3):e495-e498. PubMed ID: 35959783
[TBL] [Abstract][Full Text] [Related]
6. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients.
Sarrell BA; Bloch K; El Chediak A; Kumm K; Tracy K; Forbes RC; Langone A; Thomas L; Schlendorf K; Trindade AJ; Perri R; Wright P; Concepcion BP
Transpl Infect Dis; 2022 Feb; 24(1):e13759. PubMed ID: 34787345
[TBL] [Abstract][Full Text] [Related]
9. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
10. Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19.
Jabr R; Khatri A; Anderson AD; Garcia LC; Viotti JB; Natori Y; Raja M; Camargo JF; Morris MI
Transpl Infect Dis; 2023 Feb; 25(1):e14006. PubMed ID: 36704987
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Outcomes and Vaccinations in Swedish Solid Organ Transplant Recipients 2020-2021: A Nationwide Multi-Register Comparative Cohort Study.
Søfteland JM; Li H; Magnusson JM; Leach S; Friman V; Gisslén M; Felldin M; Schult A; Karason K; Baid-Agrawal S; Wallquist C; Nyberg F
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400046
[TBL] [Abstract][Full Text] [Related]
12. Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation-A Danish nationwide cohort study.
Overvad M; Koch A; Jespersen B; Gustafsson F; Krause TG; Hansen CH; Ethelberg S; Obel N
Am J Transplant; 2022 Nov; 22(11):2627-2636. PubMed ID: 35801493
[TBL] [Abstract][Full Text] [Related]
13. Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies.
Candel FJ; Salavert M; Lorite Mingot D; Manzano Crespo M; Pérez Portero P; Cuervo Pinto R
Rev Esp Quimioter; 2023 Aug; 36(4):380-391. PubMed ID: 37089055
[TBL] [Abstract][Full Text] [Related]
14. Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave.
Al Jurdi A; Morena L; Cote M; Bethea E; Azzi J; Riella LV
Am J Transplant; 2022 Dec; 22(12):3130-3136. PubMed ID: 35727916
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus Disease 2019 (COVID-19) in Heart Transplant Recipients and Anti-SARS-CoV-2 Monoclonal Antibodies: Experience, Lessons Learnt, and Future Challenges.
Kapur R; Okumura K; Ohira S; Isath A; Gandhi A; Keller M; Nog R; Gass A; Spielvogel D; Lansman S; Dhand A
Cardiol Rev; 2024 Feb; ():. PubMed ID: 38334977
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.
Subramanian V
J Infect Dis; 2023 Aug; 228(Suppl 1):S34-S45. PubMed ID: 37539762
[TBL] [Abstract][Full Text] [Related]
17. Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients.
Karaba AH; Zhu X; Benner SE; Akinde O; Eby Y; Wang KH; Saraf S; Garonzik-Wang JM; Klein SL; Bailey JR; Cox AL; Blankson JN; Durand CM; Segev DL; Werbel WA; Tobian AAR
Transplantation; 2022 Apr; 106(4):835-841. PubMed ID: 35085183
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.
Mrzljak A; Jureković Ž; Pavičić-Šarić J; Stevanović V; Tabain I; Hruškar Ž; Mikulić D; Barbić L; Vilibić-Čavlek T
Biochem Med (Zagreb); 2021 Oct; 31(3):030901. PubMed ID: 34658649
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Bebtelovimab Therapy in Patients With Solid Organ Transplantation With Mild and Moderate COVID-19.
Kapur R; Okumura K; Feola N; Keller M; Dhand A
Cureus; 2023 May; 15(5):e38867. PubMed ID: 37313067
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.
Piccicacco N; Zeitler K; Montero J; Kumar A; Lakshmi S; Kim K; Wein D; Vasey T; Vasey M; Oxner A
Open Forum Infect Dis; 2021 Jul; 8(7):ofab292. PubMed ID: 34258319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
